Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | TAOK1 | Q7L7X3 | 3/20 | 0.39 |
| ▸ | TAOK3 | Q9H2K8 | 3/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1471074 | 0.84 | S1PR1 (0.36) | CTSDBACE1PPARGPPARATAOK1 | |
| SCHEMBL12749385 | 0.82 | S1PR1 (0.50) | CTSDBACE1PPARGPPARATAOK1 | |
| SCHEMBL2285235 | 0.72 | PPARA (0.40) | PPARGPPARAS1PR1S1PR3S1PR4 | |
| SCHEMBL2283157 | 0.72 | S1PR1 (0.54) | PPARGPPARAS1PR1S1PR3S1PR4 | |
| SCHEMBL1473437 | 0.71 | S1PR1 (0.52) | CTSDBACE1TAOK1TAOK3EPHX1 | |
| SCHEMBL2283468 | 0.71 | PPARA (0.43) | PPARGPPARAS1PR1S1PR3S1PR4 | |
| SCHEMBL2008551 | 0.71 | S1PR1 (0.46) | PPARGPPARAS1PR1S1PR3S1PR4 | |
| SCHEMBL2011162 | 0.71 | PPARA (0.42) | PPARGPPARAS1PR1S1PR3S1PR4 | |
| SCHEMBL14206102 | 0.71 | S1PR1 (0.42) | PPARGPPARATAOK1TAOK3EPHX1 | |
| SCHEMBL13645061 | 0.70 | S1PR1 (0.52) | CTSDBACE1TAOK1TAOK3EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7915315-B2 | Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-03-29 | — | — | US | disclosed |
| US-20090253761-A1 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253761-A1 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | S1PR1, S1PR4, S1PR2 | CTSD 3273/4885BACE1 2180/4885PPARG 769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.